As of 2025-11-05, the Relative Valuation of Catalyst Pharmaceuticals Inc (CPRX) is 25.01 USD. This relative valuation is based on P/E multiples. With the latest stock price at 21.34 USD, the upside of Catalyst Pharmaceuticals Inc based on Relative Valuation is 17.2%.
The range of the Relative Valuation is 22.65 - 33.58 USD.
| Range | Selected | |
| Trailing P/E multiples | 13.5x - 16.0x | 14.9x |
| Forward P/E multiples | 15.9x - 23.6x | 17.3x |
| Fair Price | 22.65 - 33.58 | 25.01 |
| Upside | 6.2% - 57.4% | 17.2% |
| Date | P/E |
| 2025-11-04 | 12.52 |
| 2025-11-03 | 12.58 |
| 2025-10-31 | 12.48 |
| 2025-10-30 | 12.30 |
| 2025-10-29 | 12.32 |
| 2025-10-28 | 12.53 |
| 2025-10-27 | 12.55 |
| 2025-10-24 | 12.29 |
| 2025-10-23 | 12.16 |
| 2025-10-22 | 12.30 |
| 2025-10-21 | 12.57 |
| 2025-10-20 | 12.32 |
| 2025-10-17 | 12.05 |
| 2025-10-16 | 12.04 |
| 2025-10-15 | 12.47 |
| 2025-10-14 | 11.91 |
| 2025-10-13 | 11.97 |
| 2025-10-10 | 11.94 |
| 2025-10-09 | 12.21 |
| 2025-10-08 | 11.96 |
| 2025-10-07 | 12.21 |
| 2025-10-06 | 12.16 |
| 2025-10-03 | 12.22 |
| 2025-10-02 | 12.22 |
| 2025-10-01 | 12.26 |
| 2025-09-30 | 11.55 |
| 2025-09-29 | 11.47 |
| 2025-09-26 | 11.45 |
| 2025-09-25 | 11.22 |
| 2025-09-24 | 11.55 |
| 2025-09-23 | 11.60 |
| 2025-09-22 | 11.76 |
| 2025-09-19 | 11.60 |
| 2025-09-18 | 11.97 |
| 2025-09-17 | 11.74 |
| 2025-09-16 | 11.77 |
| 2025-09-15 | 11.59 |
| 2025-09-12 | 11.71 |
| 2025-09-11 | 11.88 |
| 2025-09-10 | 11.58 |
| 2025-09-09 | 11.73 |
| 2025-09-08 | 11.78 |
| 2025-09-05 | 11.90 |
| 2025-09-04 | 11.61 |
| 2025-09-03 | 11.61 |
| 2025-09-02 | 12.05 |
| 2025-08-29 | 12.08 |
| 2025-08-28 | 11.95 |
| 2025-08-27 | 11.84 |
| 2025-08-26 | 11.70 |